Posted on

New Treatment for Eczema

Eczema treatment

New Treatment for Eczema
Dupilumab is a monoclonal antibody which has proven to reduce up 75% of symptoms-score of itching in atopic eczema. Approved for adults in 2017 for treatment of adults with moderate to severe disease, Dupulimab has given physicians a new tool to treat the condition for which there was no satisfactory cure. Also, this is a drug with no alarming safety concerns.
Powlin Manuel MD, MBA, MS.
Pediatric allergist

Leave a Reply

Your email address will not be published. Required fields are marked *